Global Immune Response Testing Market
Healthcare Services

Immune Response Testing Market Analysis Reflecting Expansion Trends And Industry Performance

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Size Of The Immune Response Testing Market Progress Through 2030?

The immune response testing market size has experienced swift expansion in recent years. This market is set to expand from $16.36 billion in 2025 to $18.09 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.6%. Historically, this growth has been driven by the increasing prevalence of immune-related disorders, a wider application of antibody-based diagnostics, the expansion of clinical immunology laboratories, the growing adoption of ELISA testing methods, and heightened vaccine response monitoring.

The immune response testing market is projected to experience substantial expansion over the upcoming years. This market is forecast to reach $26.76 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.3%. The anticipated growth during this period stems from several factors, including the increasing demand for personalized immune profiling, the rising application of immune monitoring in oncology and vaccines, the broadening of point-of-care immune testing, the growing integration of AI into diagnostic interpretation, and an increasing emphasis on the early detection of immune dysfunction. Key trends anticipated for the forecast period encompass the increasing adoption of multiplex immune assays, the rising utilization of cellular immune response analysis, the growing integration of automated testing platforms, the expansion of high-sensitivity diagnostic panels, and an enhanced focus on immune monitoring.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27314&type=smp

Which Core Factors Are Supporting The Expansion Of The Immune Response Testing Market?

The increasing incidence of autoimmune conditions is anticipated to drive the expansion of the immune response testing market in the future. These diseases are characterized by the immune system erroneously targeting and damaging the body’s own healthy cells and tissues. The rising occurrence of autoimmune disorders is largely attributed to greater exposure to environmental contaminants, which can impair immune system function and provoke attacks on the body’s native tissues. Immune response testing improves the management of autoimmune diseases by offering accurate information about the body’s immune actions, facilitating prompt diagnosis and tailored therapeutic strategies. This testing aids in more effective disease surveillance and contributes to enhanced patient results via adjustments in targeted therapies. For example, data from Arthritis Australia, an Australian non-profit, indicated in February 2024 that an estimated 562,378 Australians would be afflicted with RA by 2025, constituting 14% of all arthritis cases in that year. This figure is projected to climb by 33% to 748,721 people by 2040, signifying an additional 186,343 Australians living with RA compared to 2025. Consequently, the increasing incidence of autoimmune diseases is propelling the expansion of the immune response testing market.

How Is The Immune Response Testing Market Examined Through Segment Analysis?

The immune response testing market covered in this report is segmented –

1) By Type Of Testing: Antibody Testing, Cytokine Testing, Cellular Testing, Complement System Testing

2) By Application: Allergy Testing, Human Immunodeficiency Virus (HIV) Disease, Cancer, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Other Applications

3) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Home Care Settings

Subsegments:

1) By Antibody Testing: Immunoglobulin G (IgG) Testing, Immunoglobulin A (IgA) Testing, Immunoglobulin M (IgM) Testing, Neutralizing Antibody Testing, Rapid Antibody Testing

2) By Cytokine Testing: Enzyme-Linked Immunosorbent Assay (ELISA)-Based Cytokine Assays, Multiplex Cytokine Assays, Flow Cytometry-Based Cytokine Assays, Cytometric Bead Array, Quantitative Polymerase Chain Reaction (qPCR)-Based Cytokine Analysis

3) By Cellular Testing: T-Cell Response Assays, B-Cell Response Assays, Natural Killer (NK) Cell Assays, Lymphocyte Proliferation Assays, ELISpot Assays

4) By Complement System Testing: Total Hemolytic Complement (CH50) Assay, Alternative Pathway Hemolytic Complement (AH50) Assay, Complement Component 3 And 4 (C3 And C4) Complement Testing, Mannose-Binding Lectin (MBL) Testing, Complement Activity Assays

Which Trends Are Influencing The Direction Of The Immune Response Testing Market?

Leading firms within the Immune Response Testing market are concentrating on creating novel solutions, including immune profiling technologies, to address the increasing need for sophisticated diagnostics concerning post-viral conditions and the evaluation of adaptive immunity. These immune profiling technologies offer a thorough examination of the immune system, evaluating both cellular and humoral immune responses, thereby yielding deeper insights than conventional serological tests primarily focused on antibody detection. A notable example occurred in April 2024 when Virax Biolabs Group Limited, a UK-based biotechnology company, unveiled its range of immune profiling solutions at ESCMID Global 2024, specifically aimed at assessing adaptive immunity in post-viral states. These solutions integrate advanced assays, such as multi-parametric flow cytometry and specialized biomarker panels, allowing for the precise identification of immune cell subgroups and their functional activities. Key characteristics encompass high sensitivity, adaptable panels tailored for diverse post-viral syndromes, and seamless integration with digital reporting systems for simplified data analysis. Their applications span from clinical research to individualized patient surveillance, providing advantages like the early identification of immune system irregularities and aiding in therapeutic choices.

Who Are The Companies Shaping The Immune Response Testing Market Landscape?

Major companies operating in the immune response testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare GmbH, Becton Dickinson and Company, Quest Diagnostics Incorporated, Eurofins Scientific SE, PerkinElmer Inc., bioMérieux SA, Bruker Corporation, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Qiagen N.V., DiaSorin S.p.A., EUROIMMUN Medizinische Labor diagnostika AG, NanoString Technologies Inc., GenScript Biotech Corporation, Cell Signaling Technology Inc., Sysmex Corporation, Ortho Clinical Diagnostics, Randox Laboratories Ltd., Merck KGaA

Access The Complete Immune Response Testing Market Report:

https://www.thebusinessresearchcompany.com/report/immune-response-testing-global-market-report

Which Geographic Region Represents The Largest Immune Response Testing Market Share?

North America was the largest region in the immune response testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immune response testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Immune Response Testing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=27314&type=smp

Browse Through More Reports Similar to the Global Immune Response Testing Market 2026, By The Business Research Company

Nanomaterials Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/nanomaterials-global-market-report

Nanosilica Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/nanosilica-global-market-report

Nanofibers Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/nanofibers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model